Integra LifeSciences Holdings Corporation (IART)

IART Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	276.4	456.66	513.45	470.17	198.91
Short-Term Investments	32.69	0	0	0	0
Cash & Cash Equivalents	309.1	456.66	513.45	470.17	198.91
Cash Growth	-32.31%	-11.06%	9.21%	136.37%	43.27%
Receivables	259.33	263.47	231.83	225.53	275.3
Inventory	389.61	324.58	317.39	310.12	316.05
Other Current Assets	100.01	116.79	91.05	231.39	67.91
Total Current Assets	1,058	1,161	1,154	1,237	858.17
Property, Plant & Equipment	496.38	459.59	396.25	371.16	431.93
Goodwill and Intangibles	2,123	2,165	2,159	1,922	1,986
Other Long-Term Assets	104.27	103.18	73.39	84.97	27.27
Total Long-Term Assets	2,724	2,728	2,629	2,378	2,445
Total Assets	3,782	3,890	3,782	3,615	3,303
Accounts Payable	92.33	102.1	61.84	54.61	113.09
Deferred Revenue	8.54	7.25	5.3	5.28	4.77
Current Debt	29.82	52.75	59.78	159.07	57.25
Other Current Liabilities	176.3	158.8	213.11	182.06	156.19
Total Current Liabilities	306.98	320.91	340.02	401.01	331.31
Long-Term Debt	1,652	1,563	1,592	1,496	1,401
Other Long-Term Liabilities	235.26	201.84	166.05	202.92	154.63
Total Long-Term Liabilities	1,887	1,764	1,758	1,699	1,555
Total Liabilities	2,194	2,085	2,098	2,100	1,887
Total Debt	1,682	1,615	1,651	1,655	1,458
Debt Growth	4.11%	-2.18%	-0.25%	13.55%	7.65%
Retained Earnings	946.86	879.12	698.57	532.27	398.57
Comprehensive Income	-15.11	10.27	-45.16	-74.06	-76.4
Shareholders' Equity	1,588	1,804	1,685	1,515	1,417
Net Cash / Debt	-1,372.59	-1,158.7	-1,137.84	-1,185.24	-1,258.91
Net Cash Per Share	-17.09	-13.87	-13.31	-13.91	-14.55
Working Capital	751.06	840.59	813.7	836.19	526.86
Book Value Per Share	19.83	21.74	19.89	17.90	16.54

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).